TABLE 39A LIST OF PUBLICATIONS REFERRED TO IN THE ...

2003;1:471-82.
14A.278 Walker MD et al. Neuroparasitic infections: cestodes, trematodes and protozoans. Semin Neurol
2005;25:262-77.
14A.279 Keiser J et al. Food-borne trematodiasis: current chemotherapy and advances with artemisinins and
synthetic trioxolanes. Trends Parasitol 2007;23:555-62.
14A.280 Keiser J et al. Food-borne trematodiases. Clin Microbiol Rev 2009;22:466-83.
14A.281 Marcos LA et al. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr
Opin Infect Dis 2008;21:523-30.
14A.282 Lun ZR et al. Clonorchiasis: a key foodborne zoonosis in China. Lancet Infect Dis 2005;5:31-41.
14A.283 Sing A. Of ants and men (an antology). Clin Infect Dis 2007;44:145-6.
14A.284 Marcos LA et al. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr
Opin Infect Dis 2008;21:523-30.
14A.285 Mas-Coma S et al. Fascioliasis and other plant borne trematode zoonoses. Int J Parasitol 2005;35:
1255-78.
14A.286 Keiser J et al. Artemisinins and synthetic trioxolanes in the treatment of helminth infections. Curr
Opin Infect Dis 2007;20:605-12.
14A.287 Mas-Coma S et al. Fascioliasis and other plant borne trematode zoonoses. Int J Parasitol 2005;35:
1255-78.
14A.288 MacLean JD et al. Common source outbreak of acute infection due to the North American liver fluke
Metorchis conjunctus. Lancet 1996;347:154-8.
14A.289 Marcos LA et al. Update on hepatobiliary flukes: fascioliasis, opisthorchiasis and clonorchiasis. Curr
Opin Infect Dis 2008;21:523-30.
14A.290 Lane MA et al. Human paragonimiasis in North America following ingestion of raw crayfish. Clin Infect
Dis 2009;49:e55-61.
14A.291 Jauréguiberry S et al. Acute schistosomiasis: a diagnostic and therapeutic challenge. Clin Microbiol
Infect 2010;16:225-31.
14A.292 Leshem E et al. Acute schistosomiasis outbreak: clinical features and economic impact. Clin Infect
Dis 2008;47:1499-1506.
14A.293 Gryseels B et al. Human schistosomiasis. Lancet 2006;368:1106-18.
14A.294 Blanchard TJ. Schistosomiasis. Travel Med Infect Dis 2004;2:5-11.
14A.295 Ross AG et al. Schistosomiasis. N Engl J Med 2002;346:1212-20.
14A.296 Silva LS et al. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids
and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infect Dis 2004;39:1618-
24.
14A.297 Carod-Artal J. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg
2008;102:107-16.
14A.298 Ross AG et al. Katayama syndrome. Lancet Infect Dis 2007;7:218-24.
14A.299 Bottieau E et al. Imported Katayama fever: clinical and biological features at presentation and during
treatment. J Infect 2006;52:339-45.
14A.300 Fölster-Holst R et al. Cercarial dermatitis contracted via contact with an aquarium: case report and review.
Br J Dermatol 2001;145:638-40.
14A.301 Burkhart CG et al. Swimmer‘s itch: an assessment proposing possible treatment with ivermectin. Int J
Dermatol 2003;42:917-8.
14A.302 Raether W et al. Epidemiology, clinical manifestations and diagnosis of zoonotic cestode infections:
an update. Parasitol Res 2003;91:412-38.
14A.303 Walker MD et al. Neuroparasitic infections: cestodes, trematodes and protozoans. Semin Neurol
2005;25:262-77.
14A.304 Garcia HH. Antiparasitic drugs in neurocysticercosis: albendazole or praziquantel. Expert Rev Anti
Infect Ther 2008;6:295-8.
14A.305 Carpio A et al. Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial.
J Neurol Neurosurg Psychiatry 2008;79:1050-5.
14A.306 Garg RK. Treatment of neurocysticercosis: is it beneficial? Expert Rev Anti Infect Ther 2008;6:435-
40.
14A.307 Kaur S et al. Combination therapy with albendazole and praziquantel versus albendazole alone in
children with seizures and single lesion neurocysticercosis a randomized, placebo-controlled double
blind trial. Pediatr Infect Dis J 2009;28:403-6.
14A.308 White AC. New developments in the management of neurocysticercosis. J Infect Dis 2009;199:
1261-2.
14A.309 Serpa JA et al. Advances in the diagnosis and management of human neurocysticercosis. Expert
Rev Anti Infect Ther 2006;4:1051-61.
14A.310 Del Brutto OH et al. Meta-analysis. Cysticidal drugs for neurocysticercosis: albendazole and praziquantel.
Ann Intern Med 2006;145:43-51.
14A.311 Schantz PM. Progress in diagnosis, treatment and elimination of echinococcosis and cysticercosis.
Parasitol Int 2006;5(suppl. 1):S7-13.
14A.312 García HH et al. Taenia solium cysticercosis. Lancet 2003;362:547-56.
14A.313 Carpio A. Neurocysticercosis: an update. Lancet Infect Dis 2002;2:751-62.
14A.314 Garcia HH et al. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis.
N Engl J Med 2004;350:249-58.
14A.315 Garcia HH et al. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium).
Am J Trop Med Hyg 2005;72:3-9.
14A.316 Abba K et al. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010;
3:CD000215.
14A.317 Garg RK. Antiparasitic treatment for solitary cysticercus granuloma: to treat or not to treat? Expert
Rev Anti Infect Ther 2008;6:15-9.
14A.318 Baranwal AK et al. Albendazole therapy in children with focal seizures and single small enhancing
computerized tomographic lesions: a randomized, placebo-controlled, double blind trial. Pediatr Infect
Dis J 1998;17:696-700.
14A.319 Proaño JV et al. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts.
N Engl J Med 2001;345:879-85.
14A.320 Vazquez ML et al. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously.
Neurology 1987;37:1561-2.
14A.321 Jung H et al. Dexamethasone increases plasma levels of albendazole. J Neurol 1990;237:279-80.
14A.322 Mitre E et al. Methotrexate as corticosteroid-sparing agent in complicated neurocysticercosis. Clin In-